Home
  Mypage
  Top
  • Sponsored Symposium 1
    (MSD Korea Co. , Ltd.)
  • October 26 (Wed) 11:30 - 12:30
    Ruby Hall, Yeong Bin Gwan
    Current Status of Pneumococcal Prevention and Future Prospects
    (Chairperson) Kyung-Hyo Kim, Ewha Womans University College of Medicine (Republic of Korea)

    Role of Vaccines in Fighting Against Antimicrobial Resistance
    George Zhanel, University of Manitoba (Canada)

    Pneumococcal Disease and Prevention in AP Region; Current Status and Future Direction
    Chun-Yi Lu, National Taiwan University Children’s Hospital (Taiwan)
  • Sponsored Symposium 2
    (Boryung Co.)
  • October 26 (Wed) 11:30 - 12:30
    Topaz Hall, Yeong Bin Gwan
    The Use of Cefepime in Children
    (Chairperson) Dae Sun Jo, Jeonbuk National University Children’s Hospital/Jeonbuk National University Medical School (Republic of Korea)

    The Use of Cefepime in Children
    Hyun Mi Kang, The Catholic University of Korea Seoul St. Mary's Hospital (Republic of Korea)
  • Sponsored Symposium 3
    (Pfizer)
  • October 26 (Wed) 15:15 - 16:15
    Ruby Hall, Yeong Bin Gwan
    Pneumococcal Disease: Past, Present, and Future
    (Chairperson) Hoan Jong Lee, Seoul National University College of Medicine (Republic of Korea)

    The Impact of COVID-19 Pandemic on Pneumococcus-Associated Disease
    Ron Dagan, Ben Gurion University (Israel)

    Panel Discussion and Q&A - What is Coming Next?
    Hoan Jong Lee, Seoul National University College of Medicine (Republic of Korea)
    Ron Dagan, Ben Gurion University (Israel)
    Anna Lisa Ong-Lim, University of Philippines Manila (Philippines)
  • Sponsored Symposium 4
    (Sanofi)
  • October 26 (Wed) 15:15 - 16:15
    Topaz Hall, Yeong Bin Gwan
    Why Hexavalent Vaccine? - Current Global Trend of Hexavalent Vaccine Use and Advantage of Hexavalent Vaccine in Preventing DTaP/Polio/Hib and HepB
    (Chairperson) Su Eun Park, Pusan National University Children's Hospital (Republic of Korea)

    Benefit of Hexavalent Vaccine Use and Experience Sharing of Hexavalent Vaccine Inclusion in NIP
    Thahira Jamal Mohamed, Women and Children Hospital Kuala Lumpur (Malaysia)

    Current Global Trend of Hexavalent Vaccine Use & HepB Prevention / Vaccination Schedule Change and Implementation
    Wanatpreeya Phongsamart, Siriraj Hospital, Mahidol University (Thailand)
  • Luncheon Symposium 1
    (SK bioscience)
  • October 27 (Thu) 11:45 - 12:45
    Ruby Hall, Yeong Bin Gwan
    The Integrity to Prepare for The Pandemic
    (Chairperson) Kenneth McIntosh, Harvard Medical School (USA)

    Introduction of SKYCOVIONE(COVID-19 Vaccine)
    Sushant Sahastrabuddhe, International Vaccine Institute (IVI)

    CEPI and The 100 Days Mission: preparing for future epidemic and pandemic threats
    Richard Hatchett, Coalition for Epidemic Preparedness Innovations (CEPI) (UK)

    SK Bioscience and their Next Pandemic Preparation
    Justis Taejun Cho, SK bioscience (Republic of Korea)
  • Luncheon Symposium 2
    (GC Biopharma)
  • October 27 (Thu) 11:45 - 12:45
    Topaz Hall, Yeong Bin Gwan
    New MAV/06 Varicella Vaccine (BARYCELA inj.) & Effectiveness of the Varicella Vaccine in Korea
    (Chairperson) Jin-Han Kang, The Catholic University of Korea Seoul St. Mary's Hospital (Republic of Korea)

    Immunogenicity and Safety of BARYCELA inj., New MAV/06 Strain Varicella Vaccine
    Hyun Mi Kang, The Catholic University of Korea Seoul St. Mary's Hospital (Republic of Korea)

    Safety of the Live Attenuated MAV/06 Strain Varicella Vaccine in Children After Hematopoietic Stem Cell Transplantation
    Hyun Mi Kang, The Catholic University of Korea Seoul St. Mary's Hospital (Republic of Korea)

    Effectiveness of the Varicella Vaccine in Korea: Evidence and Suggestions for Future Research
    Bong Kyu Choi, GC Biopharma (Republic of Korea)
  • Sponsored Symposium 5
    (Moderna Korea Ltd.)
  • October 27 (Thu) 14:00 - 15:00
    Ruby Hall, Yeong Bin Gwan
    Responding to the Ongoing Challenge of the SARS-CoV-2 Pandemic Using mRNA Platform Technology
    (Chairperson) Byung Wook Eun, Nowon Eulji University Hospital (Republic of Korea)

    Harnessing the Power of mRNA to Address the SARS-CoV-2 Pandemic
    Chris Clarke, Moderna, Inc. (Australia)

    SARS-CoV-2 Vaccination in the Paediatric Population
    Daryl Cheng, Royal Children’s Hospital Melbourne (Australia)

    Strategies for Addressing the Challenge of Emerging SARS-CoV-2 Variants and Sub Variants
    Rituparna Das, Moderna Therapeutics (USA)
  • Sponsored Symposium 6
    (GlaxoSmithKline Korea Limited (GSK))
  • October 27 (Thu) 14:00 - 15:00
    Topaz Hall, Yeong Bin Gwan
    Meningococcal Disease and Prevention
    (Chairperson) Philippe Buchy, GSK Vaccine R&D (GCI) (France)

    Epidemiology, Transmission, Risk Factors, Diagnosis and Vaccination Impact
    Peter Richmond, University of Western Australia (Australia)